tykhr
sign in
free sign up
Teva Pharma Industries Ltd ADR
Drug Manufacturers - Specialty & Generic
Healthcare
TEVA
1.13 B shares
NYSE US
traded
09 Apr 2025
listed
no
open
13.36
52 week high
22.77
high
14.33
52 week low
13.59
low
12.70
growth
-16.36 %
previous Close
13.59
P/E ratio
market cap
25.80 B
div yield
0
usd
Sep 2024
qoq
revenue
4.33 B
4.08 %
net incoming
-437.00 M
48.28 %
eps
0.00 %
13.11 %
eps surprise
6.15 %
net profit margin
-10.09 %
10.00 %
operating incoming
-51.00 M
-106.27 %
net change in cash
1.06 B
244.75 %
cash on hand
3.32 B
46.99 %
cost of revenue
2.18 B
2.06 %
top